Dietary intake and the insulin-like growth factor system: Effects of migration in two related populations in India and Britain with markedly different dietary intake

Public Health Nutrition

Volumn 8, Issue 6, 2005, Pages 620-627

  Heald, A H ^a   Sharma, R ^a   Anderson, S G ^b   Vyas, A ^b   Siddals, K ^a   Patel, J ^b   Bhatnagar, D ^c   Prabharkaran, D ^d   Rudenski, A ^a   Hughes, E ^e   Durrington, P ^c   Gibson, J M ^a   Cruickshank, J K ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^e SANDWELL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Diet; Ethnicity; Insulin like growth factor binding proteins; Insulin like growth factors; Migration

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CALORIC INTAKE; CARDIOVASCULAR EFFECT; COMMUNITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIETARY INTAKE; ENERGY; ENVIRONMENTAL FACTOR; FAT INTAKE; FEMALE; HUMAN; INDIA; INSULIN BLOOD LEVEL; LINEAR REGRESSION ANALYSIS; MALE; MIGRATION; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UNITED KINGDOM;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; EMIGRATION AND IMMIGRATION; ENERGY INTAKE; FEMALE; GREAT BRITAIN; HUMANS; INDIA; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED;

EID: 27644542258     PISSN: 13689800     EISSN: None     Source Type: Journal    
DOI: 10.1079/PHN2005729     Document Type: Article

References (40)

1. Keys A. Coronary heart disease - the global picture. Atherosclerosis 1975; 22: 149-92.
2. Grande F, Anderson JT, Keys A. Comparison of effects of palmitic and stearic acids in the diet on serum cholesterol in man. American Journal of Clinical Nutrition 1970; 23: 1184-93.
3. Sirtori CR, Tremoli E, Gatti E, Montanari G, Sirtori M, Colli S, et al. Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high-risk patients. American Journal of Clinical Nutrition 1986; 44: 635-42.
4. Fath KA, Alexander RW, Delafontaine P. Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta. Circulation Research 1993; 72: 271-7.
5. Ververis JJ, Ku L, Delafontaine P. Regulation of insulin-like growth factor I receptors on vascular smooth muscle cells by growth factors and phorbol esters. Circulation Research 1993; 72: 1285-92.
6. Delafontaine P. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovascular Research 1995; 30: 825-34.
7. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J Jr. Insulin-like growth factor-I enhances ventricular hypertrophy and function during the onset of experimental heart failure. Journal of Clinical Investigation 1995; 95: 619-27.
8. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, et al. Overexpression of insulin-like growth factor-I in mice protects from myocyte death after infarction, attenuating ventricular wall dilatation, wall stress and cardiac hypertrophy. Journal of Clinical Investigation 1997; 100: 1991-9.
9. Mehrhof FB, Müller FU, Bergmann MW, Li P, Yibin Wang Y, Schmitz W, et al. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Circulation 2001; 104: 2088-94.
10. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001; 50: 637-42.
11. Juul A. Serum levels of insulin-like growth factor-I and its binding proteins in health and disease. Growth Hormone and IGF Research 2003; 13: 113-70.
12. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. Circulating concentrations of insulin-like growth factor-I and the development of glucose intolerance: a prospective observational study. Lancet 2002; 359: 1740-5.
13. Cruickshank JK, Heald AH, Anderson SG, Cade JE, Sampayo J, Riste LK, et al. The epidemiology of the insulin-like growth factor system in 3 ethnic groups. American Journal of Epidemiology 2001; 154: 504-13.
14. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T. Low serum insulin-like growth factor-I is associated with increased risk of ischaemic heart disease: a population-based case-control study. Circulation 2002; 106: 939-44.
15. Laughlin GA, Barrett-Connor E, Criqui MH, Kirtz-Silverstein D. The prospective association of insulin like growth factor-I and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho-Bernardo study. Journal of Clinical Endocrinology and Metabolism 2004; 89: 114-20.
16. Heald AH, Cade JE, Cruickshank JK, Anderson S, White A, Gibson JM. The influence of dietary intake on the insulin-like growth factor (IGF) system across three ethnic groups: a population-based study. Public Health Nutrition 2003; 6: 175-80.
17. Harding S. Mortality of migrants from the Indian subcontinent to England and Wales: effect of duration of residence. Epidemiology 2003; 14: 287-9.
18. Richardson MT, Leon AS, Jacobs DR Jr, Ainsworth BE, Serfass R. Ability of the Caltrac accelerometer to assess daily physical activity levels. Journal of Cardiopulmonary Rehabilitation 1995; 15: 107-13.
19. Westwood M, Gibson JM, Davies AJ, Young RJ, White A. The phosphorylation pattern of insulin-like growth factor binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. Journal of Clinical Endocrinology and Metabolism 1994; 79: 1735-41.
20. Yates AP, Laing I. Age-related increase in haemoglobin A1c and fasting plasma glucose is accompanied by a decrease in beta cell function without change in insulin sensitivity: evidence from a cross-sectional study of hospital personnel. Diabetic Medicine 2002; 19: 254-8.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
22. Ferrannini E, Mari A. How to measure insulin sensitivity. Journal of Hypertension 1998; 16: 895-906.
23. Underwood LE, Clemmons DR, Maes M, D'Ercole AJ, Ketelslegers JM. Regulation of somatomedin-C/insulin-like growth factor I by nutrients. Hormone Research 1986; 24: 166-76.
24. Clemmons DR, Klibanski A, Underwood LE, McArthur JW, Ridgway EC, Beitins IZ, et al. Reduction of plasma immunoreactive somatomedin-C during fasting in humans. Journal of Clinical Endocrinology and Metabolism 1981; 53: 1247-50.
25. Kirschner BS, Sutton MM. Somatomedin-C levels in growth impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 1986; 91: 830-6.
26. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Koumantaki Y, Mantzoros CS. Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. Journal of Clinical Oncology 1999; 17: 3291-8.
27. Ferraris RP, Cao QX, Prabhakaram S. Chronic but not acute energy restriction increases intestinal nutrient transport in mice. Journal of Nutrition 2001; 31: 779-86.
28. Morgan EH, Oates PS. Mechanisms and regulation of intestinal iron absorption. Blood Cells, Molecules & Disease 2002; 29: 384-99.
29. Gal-Garber O, Mabjeesh SJ, Sklan D, Uni Z. Partial sequence and expression of the gene for and activity of the sodium transporter in the small intestine of fed, starved and re-fed chickens. Journal of Nutrition 2000; 130: 2174-9.
30. O'Brien DP, Nelson LA, Huang FS, Warner BW. Intestinal adaptation: structure, function and regulation. Seminars in Paediatric Surgery 2001; 10: 56-64.
31. Lee PD, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proceedings of the Society for Experimental Biology and Medicine 1997; 216: 319-57.
32. Cruickshank JK, Cooper J, Burnett M, Macduff J, Drubra U. Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet 1991; 338: 842-7.
33. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-6.
34. Bang P, Brandt J, Degerblad M, Enberg G, Kaijser L, Thoren M, et al. Exercise induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency. European Journal of Clinical Investigation 1990; 20: 285-92.
35. Allen NE, Appleby PN, Kass R, Rinaldi S, Davey GK, Key TJ. Life style determinants of serum insulin-like growth factor-I, C-peptide and hormone binding protein levels in British women. Cancer Causes & Control 2003; 14: 65-74.
36. Hopkins NJ, Jakeman PM, Hughes SC, Holly JM. Changes in circulating insulin-like growth factor-binding protein-1 during prolonged exercise: effect of carbohydrate feeding. Journal of Clinical Endocrinology and Metabolism 1994; 79: 1887-90.
37. Cohen LA, Choi KW, Wang CX. Influence of dietary fat, calorie restriction and voluntary exercise on N-nitrosomethylurea-induced tumorigenesis in rats. Cancer Research 1988; 48: 4276-83.
38. Hursting SD, Perkins SN, Phang JM. Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proceedings of the National Academy of Sciences of the USA 1994; 91: 7036-40.
39. Mukherjee P, Sotnikov AV, Mangian HJ, Zhou JR, Visek WJ, Clinton SK. Energy intake and prostate tumor growth, angiogenesis and vascular endothelial growth factor expression. Journal of the National Cancer Institute 1999; 91: 512-23.
40. Dunn SE, Kari FW, French J, Leininger JR, Travlos J, Wilson R, et al. Dietary restriction reduces insulin-like growth factor-I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Research 1997; 57: 4667-72.